The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura,
Thymus and Heart has just been published with numerous important changes from the 2004 …

Background Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized
studies, this expert consensus document represents an initiative by the European …

Immune checkpoint inhibitor (ICI) therapies have revolutionized the management of patients
with NSCLC and have led to unprecedented improvements in response rates and survival …

Objectives The Blueprint (BP) Programmed Death Ligand 1 (PD-L1) Immunohistochemistry
Comparability Project is a pivotal academic/professional society and industrial collaboration …

Purpose: Analysis of circulating DNA in plasma can pro-vide a useful marker for earlier lung
cancer detection. This study was designed to assess the sensitivity and specificity of a …

… : G. Veronesi for the acquisition of human tissue samples; G. Draetta, D. Bergstrom, and P. …
We are indebted to the following individuals: G. Veronesi for the acquisition of human tissue …

The efficacy and cost-effectiveness of low-dose spiral computed tomography (LDCT)
screening in heavy smokers is currently under evaluation worldwide. Our screening program …

… G Pelosi was responsible for the pathological assessments. The initial draft of the report
was amended after the input of M Bellomi and F Fazio, and all researchers contributed to the …

Introduction A grading system for pulmonary adenocarcinoma has not been established. The
International Association for the Study of Lung Cancer pathology panel evaluated a set of …

Lung cancer is the first cause of cancer mortality worldwide, and its early detection is currently
the main available strategy to improve disease prognosis. While early diagnosis can be …